197
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Microemulsion-thermosensitive gel composites as in situ-forming drug reservoir for periodontitis tissue repair through alveolar bone and collagen regeneration strategy

ORCID Icon, , , , , , & show all
Pages 30-39 | Received 29 Jul 2022, Accepted 19 Dec 2022, Published online: 28 Dec 2022

References

  • Almoshari Y, Ren R, Zhang H, Jia Z, Wei X, Chen N, Li G, Ryu S, Lele SM, Reinhardt RA, et al. 2020. GSK3 inhibitor-loaded osteotropic Pluronic hydrogel effectively mitigates periodontal tissue damage associated with experimental periodontitis. Biomaterials. 261:120293.
  • Al-Musawi S, Albukhaty S, Al-Karagoly H, Almalki F. 2020. Design and synthesis of multi-functional superparamagnetic core-gold shell coated with chitosan and folate nanoparticles for targeted antitumor therapy. Nanomaterials. 11(1):32.
  • Blaszyk M, Holley RA. 1998. Interaction of monolaurin, eugenol and sodium citrate on growth of common meat spoilage and pathogenic organisms. Int J Food Microbiol. 39(3):175–183.
  • Boonlai W, Tantishaiyakul V, Hirun N, Sangfai T, Suknuntha K. 2018. Thermosensitive poloxamer 407/poly(acrylic acid) hydrogels with potential application as injectable drug delivery system. AAPS PharmSciTech. 19(5):2103–2117.
  • Cai X, Li CZ, Cao ZG, Du GF, Liu LH. 2008. Protective effect of baicalin on experimental periodontitis in rats and its possible mechanisms. Zhonghua Kou Qiang Yi Xue Za Zhi. 43(5):281–285.
  • Callender SP, Mathews JA, Kobernyk K, Wettig SD. 2017. Microemulsion utility in pharmaceuticals: implications for multi-drug delivery. Int J Pharm. 526(1-2):425–442.
  • Cirri M, Bragagni M, Mennini N, Mura P. 2012. Development of a new delivery system consisting in “drug–in cyclodextrin–in nanostructured lipid carriers” for ketoprofen topical delivery. Eur J Pharm Biopharm. 80(1):46–53.
  • Darveau RP. 2010. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 8(7):481–490.
  • Deves C, de Assuncao TM, Ducati RG, Campos MM, Basso LA, Santos DS, Batista EL. Jr. 2013. The transition state analog inhibitor of purine nucleoside phosphorylase (PNP) immucillin-H arrests bone loss in rat periodontal disease models. Bone. 52(1):167–175.
  • Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. 2006. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 23(12):2709–2728.
  • Elburki MS, Moore DD, Terezakis NG, Zhang Y, Lee HM, Johnson F, Golub LM. 2017. A novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects. J Periodontal Res. 52(2):186–200.
  • Elburki MS, Rossa C, Guimaraes MR, Goodenough M, Lee HM, Curylofo FA, Zhang Y, Johnson F, Golub LM. 2014. A novel chemically modified curcumin reduces severity of experimental periodontal disease in rats: initial observations. Mediators Inflamm. 2014:959471.
  • Fu S, Xu L, Li S, Qiu Y, Liu Y, Wu Z, Ye C, Hou Y, Hu CA. 2016. Baicalin suppresses NLRP3 inflammasome and nuclear factor-kappa B (NF-kappaB) signaling during Haemophilus parasuis infection. Vet Res. 47(1):80.
  • Giuliano E, Paolino D, Fresta M, Cosco D. 2018. Mucosal applications of poloxamer 407-based hydrogels: an overview. Pharmaceutics. 10(3):159.
  • Guo J, Yuan C, Huang M, Liu Y, Chen Y, Liu C, Chen Y. 2018. Ganoderma lucidum-derived polysaccharide enhances coix oil-based microemulsion on stability and lung cancer-targeted therapy. Drug Deliv. 25(1):1802–1810.
  • Hamed R, Al-Adhami Y, Abu-Huwaij R. 2019. Concentration of a microemulsion influences the mechanical properties of ibuprofen in situ microgels. Int J Pharm. 570:118684.
  • Jung YS, Park W, Park H, Lee DK, Na K. 2017. Thermo-sensitive injectable hydrogel based on the physical mixing of hyaluronic acid and Pluronic F-127 for sustained NSAID delivery. Carbohydr Polym. 156:403–408.
  • Kassebaum NJ, Bernabe E, Dahiya M, Bhandari B, Murray CJ, Marcenes W. 2014. Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. J Dent Res. 93(11):1045–1053.
  • Lamont RJ, Koo H, Hajishengallis G. 2018. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 16(12):745–759.
  • Li A, Khan IN, Khan IU, Yousaf AM, Shahzad Y. 2021. Gellan gum-based bilayer mucoadhesive films loaded with moxifloxacin hydrochloride and clove oil for possible treatment of periodontitis. Drug Des Devel Ther. 15:3937–3952.
  • Liu Z, Chen X, Zhang Z, Zhang X, Saunders L, Zhou Y, Ma PX. 2018. nanofibrous spongy microspheres to distinctly release miRNA and growth factors to enrich regulatory T cells and rescue periodontal bone loss. ACS Nano. 12(10):9785–9799.
  • Lu L, Rao L, Jia H, Chen J, Lu X, Yang G, Li Q, Lee KKH, Yang L. 2017. Baicalin positively regulates osteoclast function by activating MAPK/Mitf signalling. J Cell Mol Med. 21(7):1361–1372.
  • Luo W, Wang CY, Jin L. 2012. Baicalin downregulates Porphyromonas gingivalis lipopolysaccharide-upregulated IL-6 and IL-8 expression in human oral keratinocytes by negative regulation of TLR signaling. PLoS One. 7(12):e51008.
  • Mayol L, Quaglia F, Borzacchiello A, Ambrosio L, La Rotonda MI. 2008. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties. Eur J Pharm Biopharm. 70(1):199–206.
  • Moghimi SM, Hunter AC. 2000. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol. 18(10):412–420.
  • Moon SE, Kim HY, Cha JD. 2011. Synergistic effect between clove oil and its major compounds and antibiotics against oral bacteria. Arch Oral Biol. 56(9):907–916. English.
  • Moore J, White DJ, Schneiderman E, Chen H, Strand R, Grender JM. 2020. Laboratory screening evaluation of the safety of low pH oral care rinse products to dental enamel. Am J Dent. 33(3):161–164.
  • Nunez L, Aquino MD. 2012. Microbicide activity of clove essential oil (Eugenia caryophyllata). Braz J Microbiol. 43(4):1255–1260.
  • Pagano C, Giovagnoli S, Perioli L, Tiralti MC, Ricci M. 2020. Development and characterization of mucoadhesive-thermoresponsive gels for the treatment of oral mucosa diseases. Eur J Pharm Sci. 142:105125.
  • Pramod K, Ansari SH, Ali J. 2010. Eugenol: a natural compound with versatile pharmacological actions. Nat Prod Commun. 5(12):1999–2006.
  • Read E, Curtis MA, Neves JF. 2021. The role of oral bacteria in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 18(10):731–742.
  • Ruel-Gariepy E, Leroux JC. 2004. In situ-forming hydrogels–review of temperature-sensitive systems. Eur J Pharm Biopharm. 58(2):409–426.
  • Russo E, Villa C. 2019. Poloxamer hydrogels for biomedical applications. Pharmaceutics. 11(12):671.
  • Sadrameli M, Bathini P, Alberi L. 2020. Linking mechanisms of periodontitis to Alzheimer’s disease. Curr Opin Neurol. 33(2):230–238.
  • Sanz M, Marco Del Castillo A, Jepsen S, Gonzalez-Juanatey JR, D'Aiuto F, Bouchard P, Chapple I, Dietrich T, Gotsman I, Graziani F, et al. 2020. Periodontitis and cardiovascular diseases: consensus report. J Clin Periodontol. 47(3):268–288.
  • Schenkein HA, Papapanou PN, Genco R, Sanz M. 2020. Mechanisms underlying the association between periodontitis and atherosclerotic disease. Periodontol 2000. 83(1):90–106.
  • Sheshala R, Quah SY, Tan GC, Meka VS, Jnanendrappa N, Sahu PS. 2019. Investigation on solution-to-gel characteristic of thermosensitive and mucoadhesive biopolymers for the development of moxifloxacin-loaded sustained release periodontal in situ gels. Drug Deliv Transl Res. 9(2):434–443.
  • Sun JY, Li DL, Dong Y, Zhu CH, Liu J, Li JD, Zhou T, Gou JZ, Li A, Zang WJ. 2016. Baicalin inhibits toll-like receptor 2/4 expression and downstream signaling in rat experimental periodontitis. Int Immunopharmacol. 36:86–93.
  • Swain GP, Patel S, Gandhi J, Shah P. 2019. Development of moxifloxacin hydrochloride loaded in-situ gel for the treatment of periodontitis: in-vitro drug release study and antibacterial activity. J Oral Biol Craniofac Res. 9(3):190–200.
  • Tenjarla S. 1999. Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst. 16(5):461–521.
  • Tian Y, Li Y, Liu J, Lin Y, Jiao J, Chen B, Wang W, Wu S, Li C. 2022. Photothermal therapy with regulated Nrf2/NF-kappaB signaling pathway for treating bacteria-induced periodontitis. Bioact Mater. 9:428–445.
  • Timmerman MF, van der Weijden GA, van Steenbergen TJ, Mantel MS, de Graaff J, van der Velden U. 1996. Evaluation of the long-term efficacy and safety of locally-applied minocycline in adult periodontitis patients. J Clin Periodontol. 23(8):707–716.
  • Wang GF, Wu ZF, Wan L, Wang QT, Chen FM. 2006. Influence of baicalin on the expression of receptor activator of nuclear factor-kappaB ligand in cultured human periodontal ligament cells. Pharmacology. 77(2):71–77.
  • Zhang Y, Wang Y, Zhu X, Cao P, Wei S, Lu Y. 2017. Antibacterial and antibiofilm activities of eugenol from essential oil of Syzygium aromaticum (L.) Merr. & L. M. Perry (clove) leaf against periodontal pathogen Porphyromonas gingivalis. Microb Pathog. 113:396–402.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.